Your browser doesn't support javascript.
loading
Tissue specific diversification, virulence and immune response to Mycobacterium bovis BCG in a patient with an IFN-γ R1 deficiency.
Korol, Cecilia B; Shallom, Shamira J; Arora, Kriti; Boshoff, Helena I; Freeman, Alexandra F; King, Alejandra; Agrawal, Sonia; Daugherty, Sean C; Jancel, Timothy; Kabat, Juraj; Ganesan, Sundar; Torrero, Marina N; Sampaio, Elizabeth P; Barry, Clifton; Holland, Steve M; Tettelin, Hervé; Rosenzweig, Sergio D; Zelazny, Adrian M.
Affiliation
  • Korol CB; Department of Laboratory Medicine, Clinical Center, NIH , Bethesda, USA.
  • Shallom SJ; Department of Laboratory Medicine, Clinical Center, NIH , Bethesda, USA.
  • Arora K; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH , Bethesda, USA.
  • Boshoff HI; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH , Bethesda, USA.
  • Freeman AF; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH , Bethesda, USA.
  • King A; Department of Pediatric Immunology, Hospital Luis Calvo MacKenna, Universidad De , Chile, Chile.
  • Agrawal S; Department of Microbiology and Immunology, Institute for Genome Sciences, University of Maryland School of Medicine , Baltimore, USA.
  • Daugherty SC; Department of Microbiology and Immunology, Institute for Genome Sciences, University of Maryland School of Medicine , Baltimore, USA.
  • Jancel T; Department of Pharmacy, Clinical Center, NIH , Bethesda, USA.
  • Kabat J; Department Biological Imaging Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, NIH , Bethesda, USA.
  • Ganesan S; Department Biological Imaging Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, NIH , Bethesda, USA.
  • Torrero MN; Department of Laboratory Medicine, Clinical Center, NIH , Bethesda, USA.
  • Sampaio EP; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH , Bethesda, USA.
  • Barry C; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH , Bethesda, USA.
  • Holland SM; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH , Bethesda, USA.
  • Tettelin H; Department of Microbiology and Immunology, Institute for Genome Sciences, University of Maryland School of Medicine , Baltimore, USA.
  • Rosenzweig SD; Department of Laboratory Medicine, Clinical Center, NIH , Bethesda, USA.
  • Zelazny AM; Department of Laboratory Medicine, Clinical Center, NIH , Bethesda, USA.
Virulence ; 11(1): 1656-1673, 2020 12.
Article in En | MEDLINE | ID: mdl-33356838
Summary: We characterized Mycobacterium bovis BCG isolates found in lung and brain samples from a previously vaccinated patient with IFNγR1 deficiency. The isolates collected displayed distinct genomic and phenotypic features consistent with host adaptation and associated changes in antibiotic susceptibility and virulence traits. Background: We report a case of a patient with partial recessive IFNγR1 deficiency who developed disseminated BCG infection after neonatal vaccination (BCG-vaccine). Distinct M. bovis BCG-vaccine derived clinical strains were recovered from the patient's lungs and brain. Methods: BCG strains were phenotypically (growth, antibiotic susceptibility, lipid) and genetically (whole genome sequencing) characterized. Mycobacteria cell infection models were used to assess apoptosis, necrosis, cytokine release, autophagy, and JAK-STAT signaling. Results: Clinical isolates BCG-brain and BCG-lung showed distinct Rv0667 rpoB mutations conferring high- and low-level rifampin resistance; the latter displayed clofazimine resistance through Rv0678 gene (MarR-like transcriptional regulator) mutations. BCG-brain and BCG-lung showed mutations in fadA2, fadE5, and mymA operon genes, respectively. Lipid profiles revealed reduced levels of PDIM in BCG-brain and BCG-lung and increased TAGs and Mycolic acid components in BCG-lung, compared to parent BCG-vaccine. In vitro infected cells showed that the BCG-lung induced a higher cytokine release, necrosis, and cell-associated bacterial load effect when compared to BCG-brain; conversely, both strains inhibited apoptosis and altered JAK-STAT signaling. Conclusions: During a chronic-disseminated BCG infection, BCG strains can evolve independently at different sites likely due to particular microenvironment features leading to differential antibiotic resistance, virulence traits resulting in dissimilar responses in different host tissues.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / BCG Vaccine / Receptors, Interferon / Mycobacterium bovis Type of study: Prognostic_studies Limits: Animals / Child, preschool / Humans / Male Language: En Journal: Virulence Year: 2020 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / BCG Vaccine / Receptors, Interferon / Mycobacterium bovis Type of study: Prognostic_studies Limits: Animals / Child, preschool / Humans / Male Language: En Journal: Virulence Year: 2020 Document type: Article Affiliation country: United States Country of publication: United States